Tag: Atrial Fibrillation
A-Fib Contributes to Wide Range of Other Health Conditions
Review links atrial fibrillation to increased risk for cardiovascular events, kidney disease, not just stroke
Warfarin Persistence Higher Than Previously Reported in A-Fib
Risk of discontinuation increased with previous intracranial bleeding, excessive alcohol use, anemia
Canadian Cardiovascular Society Updates A-Fib Guidelines
Update focuses on management of antithrombotic tx, non-vitamin K antagonist oral anticoagulant tx
A-Fib Tied to Adverse Outcomes in Patients Undergoing PCI
Condition is linked to post-procedural bleeding, heart failure, cardiogenic shock, in-hospital mortality
DAPT Use Variable in Patients With A-Fib at Risk of Stroke
Dual antiplatelet therapy used in variable manner; most patients remain on study drug after PCI
Usual Apixaban Dosing OK With One Dose-Reduction Criterion
5 mg apixaban twice daily deemed safe, appropriate for those with one criterion in ARISTOTLE trial
